Literature DB >> 2521641

Effect of nadolol on flushing reactions in rosacea.

J K Wilkin1.   

Abstract

The effect of nadolol versus placebo on both flushing provoked in a laboratory setting and spontaneous flushing was studied in 15 patients with erythematous telangiectatic rosacea. The intensity of the flushing reactions was assessed in the laboratory by the cutaneous perfusion index method with laser-Doppler velocimetry. No effect of nadolol on the flushing reactions provoked in the laboratory was detected.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2521641     DOI： 10.1016/s0190-9622(89)70022-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  5 in total

1.  Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Authors:  J Fowler; M Jarratt; A Moore; K Meadows; A Pollack; M Steinhoff; Y Liu; M Leoni
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

Review 2.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

Review 3.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

4.  Idiopathic Flushing with Dysesthesia: Treatment with the 585nm Pulsed Dye Laser.

Authors:  Joshua P Fogelman; Mary L Stevenson; Robin Ashinoff; Nicholas A Soter
Journal:  J Clin Aesthet Dermatol       Date:  2015-08

Review 5.  Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.

Authors:  E J van Zuuren; Z Fedorowicz; J Tan; M M D van der Linden; B W M Arents; B Carter; L Charland
Journal:  Br J Dermatol       Date:  2019-03-10       Impact factor: 9.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.